When Cancer Cells Become the Enablers of an Antitumor Immune Response

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer discovery 2022-10, Vol.12 (10), p.2244-2248
Hauptverfasser:	Ribas, Antoni, Haining, W. Nicholas, Schumacher, Ton N.M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	2248
container_issue	10
container_start_page	2244
container_title	Cancer discovery
container_volume	12
creator	Ribas, Antoni Haining, W. Nicholas Schumacher, Ton N.M.
description
doi_str_mv	10.1158/2159-8290.CD-22-0706
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2721636452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2721636452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c330t-67e350ec86cd930e4b3e2ec8b4e9e5861bce3e0b598abbf38a910ce1e9c360523</originalsourceid><addsrcrecordid>eNo9kE9LAzEQxYMoWGq_gYccvWzN_90c63bVQkEQxWNI4iyt7CY12T347e1a6VzevMdjGH4I3VKypFRW94xKXVRMk2W9LhgrSEnUBZqd48vzXoprtMj5ixxHaCFJOUPNxw4Crm3wkHANXZfxA_jYAx52gJtgXQcp49hiG_AqDPth7GPCm74fA-BXyIcYMtygq9Z2GRb_Okfvj81b_VxsX5429WpbeM7JUKgSuCTgK-U_NScgHAd2tE6ABlkp6jxwIE7qyjrX8spqSjxQ0J4rIhmfo7vT3UOK3yPkwfT77I9f2wBxzIaVjCquxF9VnKo-xZwTtOaQ9r1NP4YSM4EzExUzETL12jBmJnD8Fz6xYAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2721636452</pqid></control><display><type>article</type><title>When Cancer Cells Become the Enablers of an Antitumor Immune Response</title><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ribas, Antoni ; Haining, W. Nicholas ; Schumacher, Ton N.M.</creator><creatorcontrib>Ribas, Antoni ; Haining, W. Nicholas ; Schumacher, Ton N.M.</creatorcontrib><identifier>ISSN: 2159-8274</identifier><identifier>EISSN: 2159-8290</identifier><identifier>DOI: 10.1158/2159-8290.CD-22-0706</identifier><language>eng</language><ispartof>Cancer discovery, 2022-10, Vol.12 (10), p.2244-2248</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c330t-67e350ec86cd930e4b3e2ec8b4e9e5861bce3e0b598abbf38a910ce1e9c360523</citedby><cites>FETCH-LOGICAL-c330t-67e350ec86cd930e4b3e2ec8b4e9e5861bce3e0b598abbf38a910ce1e9c360523</cites><orcidid>0000-0003-3669-8458 ; 0000-0003-0517-8804 ; 0000-0001-7871-3762</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids></links><search><creatorcontrib>Ribas, Antoni</creatorcontrib><creatorcontrib>Haining, W. Nicholas</creatorcontrib><creatorcontrib>Schumacher, Ton N.M.</creatorcontrib><title>When Cancer Cells Become the Enablers of an Antitumor Immune Response</title><title>Cancer discovery</title><issn>2159-8274</issn><issn>2159-8290</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kE9LAzEQxYMoWGq_gYccvWzN_90c63bVQkEQxWNI4iyt7CY12T347e1a6VzevMdjGH4I3VKypFRW94xKXVRMk2W9LhgrSEnUBZqd48vzXoprtMj5ixxHaCFJOUPNxw4Crm3wkHANXZfxA_jYAx52gJtgXQcp49hiG_AqDPth7GPCm74fA-BXyIcYMtygq9Z2GRb_Okfvj81b_VxsX5429WpbeM7JUKgSuCTgK-U_NScgHAd2tE6ABlkp6jxwIE7qyjrX8spqSjxQ0J4rIhmfo7vT3UOK3yPkwfT77I9f2wBxzIaVjCquxF9VnKo-xZwTtOaQ9r1NP4YSM4EzExUzETL12jBmJnD8Fz6xYAA</recordid><startdate>20221005</startdate><enddate>20221005</enddate><creator>Ribas, Antoni</creator><creator>Haining, W. Nicholas</creator><creator>Schumacher, Ton N.M.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3669-8458</orcidid><orcidid>https://orcid.org/0000-0003-0517-8804</orcidid><orcidid>https://orcid.org/0000-0001-7871-3762</orcidid></search><sort><creationdate>20221005</creationdate><title>When Cancer Cells Become the Enablers of an Antitumor Immune Response</title><author>Ribas, Antoni ; Haining, W. Nicholas ; Schumacher, Ton N.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c330t-67e350ec86cd930e4b3e2ec8b4e9e5861bce3e0b598abbf38a910ce1e9c360523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ribas, Antoni</creatorcontrib><creatorcontrib>Haining, W. Nicholas</creatorcontrib><creatorcontrib>Schumacher, Ton N.M.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ribas, Antoni</au><au>Haining, W. Nicholas</au><au>Schumacher, Ton N.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>When Cancer Cells Become the Enablers of an Antitumor Immune Response</atitle><jtitle>Cancer discovery</jtitle><date>2022-10-05</date><risdate>2022</risdate><volume>12</volume><issue>10</issue><spage>2244</spage><epage>2248</epage><pages>2244-2248</pages><issn>2159-8274</issn><eissn>2159-8290</eissn><doi>10.1158/2159-8290.CD-22-0706</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-3669-8458</orcidid><orcidid>https://orcid.org/0000-0003-0517-8804</orcidid><orcidid>https://orcid.org/0000-0001-7871-3762</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 2159-8274
ispartof	Cancer discovery, 2022-10, Vol.12 (10), p.2244-2248
issn	2159-8274 2159-8290
language	eng
recordid	cdi_proquest_miscellaneous_2721636452
source	American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title	When Cancer Cells Become the Enablers of an Antitumor Immune Response
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T18%3A05%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=When%20Cancer%20Cells%20Become%20the%20Enablers%20of%20an%20Antitumor%20Immune%20Response&rft.jtitle=Cancer%20discovery&rft.au=Ribas,%20Antoni&rft.date=2022-10-05&rft.volume=12&rft.issue=10&rft.spage=2244&rft.epage=2248&rft.pages=2244-2248&rft.issn=2159-8274&rft.eissn=2159-8290&rft_id=info:doi/10.1158/2159-8290.CD-22-0706&rft_dat=%3Cproquest_cross%3E2721636452%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2721636452&rft_id=info:pmid/&rfr_iscdi=true